BioRestorative Therapies, Inc.
BRTX
$1.09
$0.010.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -178.39% | 34.06% | -140.17% | 28.99% | -122.89% |
| Total Depreciation and Amortization | 8.90% | 10.48% | 21.31% | 18.03% | 14.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 69.12% | -109.34% | 650.49% | -256.29% | 85.75% |
| Change in Net Operating Assets | 59.78% | -53.73% | 93.44% | -31.37% | 22.96% |
| Cash from Operations | -70.69% | -44.43% | -19.89% | -47.85% | -44.11% |
| Capital Expenditure | 100.00% | 100.00% | -- | 82.29% | -391.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.72% | -29.13% | 148.77% | 10,539.19% | 10,687.23% |
| Cash from Investing | 113.24% | -28.29% | 148.03% | 1,907.31% | 4,477.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -85.60% | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -231.25% | 546.32% | -- | -- |
| Cash from Financing | -- | 7,038.28% | -85.47% | -251.99% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.91% | -70.19% | 149.69% | 40.77% | -216.78% |